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Abstract
Background: Fetal superior vena cava (SVC) is essentially the single vessel returning blood from the upper body to
the heart. With approximately 80-85% of SVC blood flow representing cerebral venous return, its interrogation may
provide clinically relevant information about fetal brain circulation. However, normal reference values for fetal SVC
Doppler velocities and pulsatility index are lacking. Our aim was to establish longitudinal reference intervals for
blood flow velocities and pulsatility index of the SVC during the second half of pregnancy.
Methods: This was a prospective study of low-risk singleton pregnancies. Serial Doppler examinations were
performed approximately every 4 weeks to obtain fetal SVC blood velocity waveforms during 20–41 weeks. Peak
systolic (S) velocity, diastolic (D) velocity, time-averaged maximum velocity (TAMxV), time-averaged intensity-
weighted mean velocity (TAMeanV), and end-diastolic velocity during atrial contraction (A-velocity) were measured.
Pulsatility index for vein (PIV) was calculated.
Results: SVC blood flow velocities were successfully recorded in the 134 fetuses yielding 510 sets of observations.
The velocities increased significantly with advancing gestation: mean S-velocity increased from 24.0 to 39.8 cm/s, D-
velocity from 13.0 to 19.0 cm/s, and A-velocity from 4.8 to 7.1 cm/s. Mean TAMxV increased from 12.7 to 23.1 cm/s,
and TAMeanV from 6.9 to 11.2 cm/s. The PIV remained stable at 1.5 throughout the second half of pregnancy.
Conclusions: Longitudinal reference intervals of SVC blood flow velocities and PIV were established for the second
half of pregnancy. The SVC velocities increased with advancing gestation, while the PIV remained stable from 20
weeks to term.
Keywords: Blood flow velocity, Fetus, hemodynamics, Pulsatility index, Reference ranges, superior vena cava,
Venous Doppler
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Background
Assessment of fetal well-being is important in obstetrics
for optimizing clinical management, and for that purpose,
Doppler ultrasonography is one of the most commonly
used methods [1]. It has the capacity to detect changes in
the hemodynamics of compromised fetuses [2, 3]. In case
of hypoxemia, such fetuses are known to redistribute
blood to vital organs, i.e. brain, heart and adrenal glands
[4, 5]. On the arterial side, Doppler velocimetry of the um-
bilical and middle cerebral arteries is often used to identify
this phenomenon [6]. On the venous side, the ductus
venosus and umbilical vein are the most commonly used
for the evaluation of fetal wellbeing [7, 8]. Fetal inferior
vena cava (IVC) flow patterns have also been studied [9,
10], but these veins represent the venous return from the
lower body and the placenta. On the other hand, the su-
perior vena cava (SVC) is essentially the single vessel
returning blood to the heart from the head and upper
body. As approximately 80% of SVC blood flow comes
from the brain [11], its interrogation may provide clinic-
ally useful information. In preterm neonates, SVC blood
flow measurement has been shown to be a useful tool in
assessing hemodynamics and predicting complications,
e.g. cerebral intraventricular hemorrhage [12]. However,
this compartment of the venous circulation has not been
studied extensively in the fetus.
In 1990, Reed et al. described the blood flow velocity
waveform patterns of the SVC and IVC in normal and
growth restricted fetuses, and in fetuses with cardiac
arrhythmia demonstrating that the time-velocity integral
of diastolic waveform was lower in severly growth re-
stricted fetuses, and that the reversed end-diastolic vel-
ocity was augmented during atrial contraction in fetal
tachyarrythmias [13]. A decade later, Fouron et al. re-
ported a similar study comparing SVC and IVC Doppler
velocity waveform profiles between 15 normally grown
fetuses and 11 fetuses with absent end-diastolic flow in
the umbilical artery showing that the SVC waveforms re-
semble IVC waveforms and vice versa in growth-
restricted fetuses with severe placental insufficiency [14].
In 2012, Nyberg et al. showed that the SVC blood flow
increased significantly during fetal breathing movements
in normal pregnancy [15]. In this publication they also
presented baseline normative data on peak systolic (S)
velocity and time-averaged maximum velocity (TAMxV)
based on a total of 302 measurements obtained from
110 fetuses at 3 gestational age windows. However, their
study and design were not aimed at establishing gesta-
tional age specific reference values for SVC velocities
nor was the pulsatility index for veins (PIV) addressed.
Accordingly, our aim for the present study was to es-
tablish longitudinal reference intervals for the fetal SVC




This was part of a prospective observational study on
fetal cardiovacular function conducted at the Department
of Obstetrics and Gynecology, University Hospital of
North Norway, Tromsø, Norway, during 2009–2012.
Pregnant women were informed about the study and re-
cruited at the time of routine ultrasound screening at
18–20 gestational weeks. A total of 142 women with un-
complicated singleton pregnancies were enrolled in the
study after obtaining written consent, and examined ap-
proximately every 4 weeks until term. Some data on im-
pedance based and volume blood flow based cerebro-
placental and umbilico-cerebral ratios from this study
population have been reported previously [16, 17].
All participants had their routine second trimester
scan when their gestational age was confirmed by the
measurement of biparietal diameter or head circumfer-
ence. Inclusion criteria were: age ≥ 18 years, uncompli-
cated singleton pregnancy, and gestational age ≥ 18
and < 24 weeks at enrollment. Exclusion criteria were:
preeclampsia in previous pregnancy, gestational diabetes
or history of preexisting maternal diseases complicating
the pregnancy, such as chronic hypertension, diabetes
mellitus or autoimmune disease. Fetuses with growth re-
striction (defined as estimated fetal weight < 10th per-
centile and umbilical artery pulsatility index >95th
percentile for the gestational age), major congenital mal-
formations or chromosomal abnormality were also
excluded.
Doppler ultrasonography
The ultrasound examinations were performed transabdom-
inally with the pregnant woman in a supine semirecumbent
position. Three specialist obstetricinas experienced in ultra-
sonography performed the Doppler ultrasonographic mea-
surements. Ultrasonography was performed using a Vivid 7
Dimension ultrasound system (GE Vingmed Ultrasound
AS, Horten, Norway) equipped with a M4S sector trans-
ducer with frequencies of 1.5–4.3MHz. At each study visit,
after confirming the presence of fetal heart activity,
fetal biometry was perfomed to estimate the fetal
weight and umbilical artery and middle cerebral ar-
tery (MCA) Doppler pulsatility indices were measured
as reported previously [16, 17].
The SVC was assessed in a long axis view where it en-
ters the right atrium. The Doppler sample gate was
placed at the point where the vessel enters the right
atrium without overlapping the ascending aorta, using
the method described previously [15, 17]. Velocimetry
was performed using color directed pulsed-wave Dop-
pler during fetal quiescence. The scale (pulse repetition
frequency) was adjusted according to velocities to avoid
aliasing. A large enough sample volume was used for
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Doppler interrogation depending on the gestational age
of the fetus and size of the SVC to ensure sampling of
the velocities from the entire lumen of the vessel. Dop-
pler insonation was aligned to SVC flow direction. When
complete alignment was not possible, angle correction
was used to reduce the error in velocity measurement,
but never exceeded 30 degrees. The wall motion filter
was set to less than 100 Hz. The 3–6 s of cine loop of
Doppler velocity waveforms were acquired at a sweep
speed of 50–100 cm/s and stored for off-line analysis.
The maximum velocity envelope of the SVC wave-
forms was automatically traced using the software of the
ultrasound machine. The trace was visually inspected
and sensitivity adjusted if required. Manual tracing was
used if automated tracing was not appropriate. The peak
systolic (S) velocity, diastolic (D) velocity, time-averaged
maximum velocity (TAMxV), time-averaged intensity
weighted mean velocity (TAMeanV) and end-diastolic
velocity during the atrial contraction (A-velocity) were
measured (Fig. 1). An average value of at least three con-
secutive cardiac cycles were recorded for analysis. The
PIV was calculated as: (S-velocity – A-velocity)/TAMxV
as described for other precordial veins [18, 19].
Clinical outcomes
All pregnant women participating in the study had regu-
lar antenatal follow-up according to clinical routine.
Data on the course of pregnancy, birth, and neonatal
outcome were collected from the electronic medical
records.
Statistical analysis
The sample size was calculated based on the formula
proposed by Royston and Altman according to which
the sample size of a longitudinal study is equivalent to
the number of participants required to construct gesta-
tional age-specific reference ranges in a cross-sectional
study divided by a design factor D (i.e. the number of fe-
tuses in a cross-sectional study that would give the same
precision as one fetus in a longitudinal study) that equals
to 2.3 [20, 21]. Assuming that approximately 15 observa-
tions per gestational week (a total of 300 pregnancies from
20 to 40 gestational week), are required in a cross-
sectional study to construct gestational age specific refer-
ence intervals with adequate precision, we calculated the
number of fetuses required for this longitudinal study to
be 300/2.3 = 130. We aimed to enroll approximately 140
pregnant women to compensate for possible unsucessful
measurements, dropouts, and loss of follow ups.
Data analysis was performed using IBM SPSS Statistics
for Windows. Version 24.0. (IBM Corp. Armonk. NY)
and MATLAB R2019a (Matworks. Inc. Natick. MA).
Data distribution for normality was checked by using the
Shapiro-Wilk test. Logarithmic or power transforma-
tions were used to achieve normal distribution of the
data. The best transformation was chosen based on the
Box-Cox transformation lambda values (λ) calculated for
each dependent variable. All SVC velocities were log10
transformed except the A-velocity that required square
(∧2) transformation, and the SVC PIV needed 1/SQRT
transformation. Best fitting fractional polynomials were
chosen to construct gestational age specific mean curves
for each variable from a list of 44 regression models
based on R2 value. Multilevel regression modeling was
used to calculate the mean and percentiles of SVC vel-
ocities and PIV in relation to gestational age taking into
account the repeated measures design of the study [22].
Association between variables were tested using mean
vector for each variable from the mixed models. A P-
value < 0.05 was considered as statistically significant.
Fig. 1 Doppler recording of the fetal superior vena cava blood velocity waveforms showing systolic peak velocity (S), diastolic peak velocity (D),
and velocity deflection during atrial contraction (A). Interference by the systolic peak in the ascending aorta (AAo) seen below the zero line
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Results
Of the 142 low-risk pregnant woman enrolled, one
was excluded from the study due to missing follow-
up data, and another seven because SVC Doppler was
not recorded. This resulted in a study population of
134 women and a total of 575 obervations with 510
(88.7%) successful recordings of adequate quality SVC
blood flow velocity waveforms. The baseline charac-
teristics of the study population and pregnancy out-
comes are presented in Table 1. There were no
perinatal deaths, but one neonate delivered at 32+ 4
weeeks by emergency cesarean section due to fetal
distress associated with abruptio placenta, had intra-
ventricular bleeding leading to hydrocephalus requir-
ing shunting. All other babies were healthy on
discharge from the hospital.
All the SVC velocities were postive (antegrade), but
the A-velocity was zero in 5.7% and negative (retro-
grade) in 8.9% of observations. The mean fetal heart rate
was 137–140 beats/min.
Gestational age-specific reference values for each SVC
velocity variables and PIV with their corresponding
2.5th, 5th, 10th, 50th, 90th, 95th and 97.5th percentiles,
are presented in Tables 2, 3, 4, 5, 6, 7.
Table 1 Baseline characteristics of the study population and
pregnancy outcomes (n = 134)
Variable Median (range),
Mean (SD) or n%
Maternal age (years) 30 (19–39)
Maternal body-mass index (Kg/cm2) 23.90 (3.80)
Nullipara 61 (45.5%)
Gestational age at birth (weeks) 40 (33–42)
Preterm delivery
< 37 weeks 4 (3.0%)
< 34 weeks 1 (0.7%)
Pre-eclampsia 4 (3.0%)
Gestational diabetes 1 (0.7%)
Induction of labor 17 (12.7%)
Mode of delivery
Normal vaginal delivery 116 (86.6%)
Operative vaginal delivery 1 (0.7%)
Cesarean section 17 (12.7%)
Birthweight (g) 3600 (2251–4636)
Sex (male/female) 74 (55) /60 (45)
Apgar score < 7 at 1 min 6 (2.2%)
Apgar score < 7 at 5 min 2 (1.4%)
Admission to neonatal inensive care 5 (3.7%)
Data are presented as median (range). mean (SD) or n (%) as appropriate
Table 2 Percentiles for fetal superior vena cava peak systolic
velocity at 20–40 weeks of gestational age (GA)
Percentile
GA (weeks) n 2.5th 5th 10th 50th 90th 95th 97.5th
20 21 15.07 16.13 17.44 23.00 30.34 32.81 35.12
21 33 15.40 16.51 17.88 23.71 31.43 34.04 36.49
22 30 15.75 16.90 18.33 24.43 32.56 35.32 37.90
23 32 16.10 17.30 18.79 25.17 33.73 36.64 39.37
24 17 16.46 17.70 19.26 25.94 34.94 38.01 40.90
25 30 16.82 18.12 19.75 26.73 36.19 39.43 42.48
26 29 17.20 18.55 20.24 27.55 37.49 40.91 44.13
27 27 17.58 18.99 20.75 28.39 38.84 42.44 45.84
28 27 17.97 19.44 21.27 29.25 40.23 44.03 47.62
29 21 18.37 19.90 21.81 30.15 41.68 45.68 49.46
30 35 18.78 20.37 22.35 31.07 43.17 47.39 51.38
31 27 19.20 20.85 22.92 32.01 44.72 49.16 53.37
32 19 19.63 21.34 23.49 32.99 46.33 51.00 55.44
33 25 20.07 21.84 24.08 34.00 47.99 52.91 57.59
34 25 20.52 22.36 24.69 35.03 49.71 54.89 59.82
35 27 20.97 22.89 25.31 36.10 51.50 56.95 62.14
36 20 21.44 23.43 25.94 37.20 53.35 59.08 64.55
37 20 21.92 23.98 26.60 38.34 55.26 61.29 67.05
38 25 22.41 24.55 27.27 39.51 57.25 63.59 69.65
39 18 22.91 25.13 27.95 40.71 59.30 65.97 72.35
40 2 23.42 25.72 28.65 41.95 61.43 68.44 75.16
Table 3 Percentiles for superior vena cava diastolic (D)-velocity
at 20–40 weeks of gestational age (GA)
Percentile
GA (weeks) n 2.5th 5th 10th 50th 90th 95th 97.5th
20 21 7.78 8.45 9.30 13.04 18.28 20.12 21.86
21 31 7.83 8.53 9.40 13.29 18.78 20.71 22.55
22 30 7.89 8.60 9.51 13.54 19.29 21.32 23.26
23 31 7.94 8.68 9.62 13.81 19.82 21.95 23.99
24 17 8.00 8.76 9.73 14.07 20.36 22.60 24.75
25 30 8.06 8.84 9.84 14.34 20.91 23.27 25.53
26 29 8.12 8.92 9.95 14.62 21.48 23.95 26.33
27 27 8.17 9.00 10.06 14.90 22.06 24.66 27.16
28 26 8.23 9.08 10.18 15.19 22.66 25.39 28.01
29 21 8.29 9.17 10.29 15.48 23.28 26.13 28.89
30 35 8.35 9.25 10.41 15.78 23.92 26.91 29.80
31 27 8.41 9.34 10.53 16.08 24.57 27.70 30.74
32 19 8.47 9.42 10.64 16.39 25.24 28.52 31.71
33 25 8.53 9.51 10.77 16.71 25.92 29.36 32.70
34 25 8.59 9.59 10.89 17.03 26.63 30.22 33.73
35 26 8.66 9.68 11.01 17.35 27.35 31.11 34.79
36 20 8.72 9.77 11.14 17.69 28.10 32.03 35.89
37 20 8.78 9.86 11.26 18.03 28.86 32.98 37.02
38 25 8.84 9.95 11.39 18.38 29.65 33.95 38.18
39 18 8.91 10.04 11.52 18.73 30.45 34.95 39.38
40 2 8.97 10.13 11.65 19.09 31.28 35.98 40.62
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The mean peak S-velocity increased with advancing
gestation from 24.0 cm/s at 20 weeks to 39.9 cm/s at 40
weeks, D-velocity from 13.0 at 20 weeks to 19.1 cm/s at
40 weeks, TAMxV from 12.7 cm/s at 20 weeks to 23.2
cm/s at 40 weeks, TAMeanV from 7.0 cm/s at 20 weeks
to 11.3 cm/s at 40 weeks, and A-velocity from 4.8 cm/s
at 20 weeks to 7.2 cm/s at 40 weeks. The SVC PIV did
not change significantly with gestational age and
remained stable at 1.50 from 20 to 40 gestational weeks
(Fig. 2). We found a significant positive correlation of
SVC S-velocity, D-velocity, TAMxV and TAMeanV with
fetal head circumference (R = 0.32 to 0.56; P < 0.0001)
and estimated fetal weight (R = 0.34 to 0.59; P < 0.0001).
The A-velocity had a weaker but significant correlation
with head circumference (R = 0.13; P = 0.003), but no
significant correlation with estimated fetal weight (R =
0.075; P = 0.091). However, the SVC PIV did not correl-
ate significantly either with fetal head circumference
(R = -0.044; P = 0.337) or with estimated fetal weight
(R = 0.013; P = 0.765). Similary, we found no significant
correlation between SVC PIV and MCA PIV (R = 0.09;
P = 0.090). However, we found a significant correlation
between SVC TAMxV and MCA TAMxV (R = 0.474;
P = < 0.0001), and SVC S-velocity with MCA peak sys-
tolic velocity (R = 0.497; P < 0.0001).
Discussion
Principal findings
This study provides longitudinal reference intervals
for Doppler-derived fetal SVC blood flow velocities
and PIV for the second half of normal pregnancy. All
velocities increased significantly with gestational age,
whereas the PIV remained stable throughout 20–40
weeks of gestation and it did not correlate signifi-
cantly with MCA PI.
Interpretation of results
Data on human fetal SVC Doppler blood flow velocity
measurements are scarce. Previous studies have mainly
focused on the diagnosis of fetal arrhythmias using sim-
ultaneous recording of SVC and ascending aorta Dop-
pler velocity waveforms to assess atrioventricular and
ventriculoartrial intervals of the cardiac cycle [23]. Al-
though two studies [14, 15] reported velocity measure-
ments of SVC blood flow, none had had the aim and
design required for establishing reference ranges for
Table 4 Percentiles for superior vena cava time-averaged
maximum velocity (TAMxV) at 20–40 weeks of gestational age
(GA)
Percentile
GA (weeks) n 2.5th 5th 10th 50th 90th 95th 97.5th
20 21 8.20 8.81 9.56 12.76 17.03 18.48 19.84
21 33 8.40 9.02 9.81 13.14 17.62 19.15 20.58
22 30 8.60 9.25 10.06 13.54 18.23 19.83 21.34
23 32 8.80 9.48 10.32 13.95 18.87 20.55 22.13
24 17 9.01 9.71 10.59 14.38 19.52 21.29 22.95
25 30 9.22 9.95 10.87 14.81 20.20 22.05 23.79
26 29 9.44 10.20 11.15 15.26 20.90 22.84 24.68
27 27 9.67 10.45 11.44 15.73 21.62 23.66 25.59
28 27 9.89 10.71 11.74 16.20 22.37 24.51 26.54
29 21 10.13 10.98 12.04 16.70 23.15 25.39 27.52
30 35 10.37 11.25 12.35 17.20 23.95 26.31 28.54
31 27 10.61 11.53 12.67 17.72 24.78 27.25 29.59
32 1 9 10.87 11.81 13.00 18.26 25.64 28.23 30.69
33 25 11.12 12.10 13.34 18.82 26.53 29.25 31.82
34 25 11.39 12.40 13.69 19.39 27.45 30.30 33.00
35 27 11.66 12.71 14.04 19.97 28.41 31.39 34.22
36 20 11.93 13.03 14.41 20.58 29.39 32.51 35.49
37 20 12.22 13.35 14.78 21.20 30.41 33.68 36.80
38 25 12.51 13.68 15.17 21.85 31.47 34.89 38.17
39 18 12.80 14.02 15.56 22.51 32.56 36.15 39.58
40 2 13.11 14.37 15.97 23.19 33.69 37.45 41.04
Table 5 Percentiles for superior vena cava time-averaged
intensity weighted mean velocity (TAMeanV) at 20–40 weeks of
gestational age (GA)
Percentile
GA (weeks) n 2.5th 5th 10th 50th 90th 95th 97.5th
20 19 4.43 4.77 5.20 7.02 9.47 10.31 11.10
21 32 4.48 4.83 5.27 7.18 9.79 10.68 11.52
22 30 4.53 4.89 5.35 7.36 10.11 11.06 11.96
23 32 4.57 4.95 5.43 7.53 10.44 11.45 12.41
24 17 4.62 5.02 5.52 7.71 10.79 11.86 12.88
25 29 4.67 5.08 5.60 7.90 11.14 12.28 13.36
26 29 4.72 5.14 5.68 8.09 11.51 12.72 13.87
27 27 4.77 5.21 5.77 8.28 11.89 13.17 14.39
28 24 4.81 5.27 5.86 8.48 12.28 13.64 14.94
29 20 4.86 5.34 5.94 8.68 12.68 14.12 15.50
30 34 4.91 5.41 6.03 8.89 13.10 14.62 16.09
31 25 4.97 5.47 6.12 9.10 13.54 15.14 16.69
32 17 5.02 5.54 6.22 9.32 13.98 15.68 17.32
33 24 5.07 5.61 6.31 9.55 14.44 16.24 17.98
34 24 5.12 5.68 6.41 9.78 14.92 16.82 18.66
35 27 5.17 5.75 6.50 10.01 15.41 17.41 19.36
36 18 5.23 5.83 6.60 10.25 15.92 18.03 20.09
37 19 5.28 5.90 6.70 10.50 16.44 18.67 20.85
38 25 5.34 5.97 6.80 10.75 16.99 19.34 21.64
39 17 5.39 6.05 6.90 11.00 17.55 20.02 22.46
40 2 5.45 6.12 7.01 11.27 18.12 20.74 23.30
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these velocities or PIV. When comparing, we note a
similar gestational age associated increase in SVC
blood flow velocities during the second half of preg-
nancy in the report published by Nyberg et al. who
studied the peak systolic velocity and time-averaged
maximum velocity at 3 different gestational age win-
dows (22–26, 28–32 and 36 weeks) during the second
half of pregnancy [15].
The SVC PIV did not change signicantly as both the
systolic and end-diastolic velocities as well as the
TAMxV increased proportionately during 20–40 weeks
of gestation. In a previous study by Fouron et al., the
SVC S-velocity was reported to be slightly higher and A-
velocity deflection during arterial contraction insignifi-
cantly deeper in fetuses with absent umbilical artery
end-diastolic flow (n = 11) compared with normal con-
trols (n = 15) [14]. This suggests an increased wave amp-
litude typically caused by increased inotropic drive of
the fetal heart during experimentally imposed hypox-
emia [24]. This is also expected to be traceable in SVC
PIV as similar velocity changes have been observed in a
study of fetal internal jugular vein Doppler in normal
and growth restricted fetuses [25]. We found a
significant correlation between SVC TAMxV and MCA
TAMxV, and SVC S-velocity with MCA peak systolic
velocity. This is plausible as these velocities are likely to
reflect cerebral blood flow volume. As the fetal cerebral
circulation is sensitive to alterations in fetal oxygenation,
the recorded mean blood velocities in the SVC (i.e.
TAMxV and TAMeanV) may increase as a marker of in-
creased blood flow. We speculate this could be an early
sign for clinical use. Furthermore, integrating SVC velo-
cimetry with diameter measurement, volume blood flow
representing venous return from the fetal head and
upper body can be calculated [15].
Strengths and limitations
One of the strengths of our study is its longitudinal de-
sign. Longitudinal studies are preferred for studying ser-
ial changes in physiological parameters with advancing
gestation compared with cross-sectional studies. Besides,
they require only about a half to a third of the sample
size needed in a cross-sectional study to estimate the
gestational age specific percentiles with the same preci-
sion [26]. Furrthermore, the longitudinal design reflects
true individual developmental change during pregnancy,
which is important for clinical monitoring using serial
Table 6 Percentiles for superior vena cava end-diastolic velocity
during atrial contraction (A-velocity) at 20–40 weeks of
gestational age (GA)
Percentile
GA (weeks) n 2.5th 5th 10th 50th 90th 95th 97.5th
20 21 −5.17 −3.05 −0.96 4.83 9.37 10.51 11.47
21 33 −5.32 −3.13 −0.98 4.96 9.58 10.75 11.72
22 30 −5.47 −3.20 −0.99 5.08 9.79 10.98 11.97
23 32 −5.63 −3.28 − 1.00 5.20 10.00 11.21 12.21
24 17 −5.79 −3.35 − 1.01 5.33 10.21 11.43 12.46
25 30 −5.94 −3.43 −1.03 5.45 10.41 11.66 12.70
26 29 −6.11 −3.51 − 1.04 5.57 10.62 11.88 12.94
27 27 −6.27 −3.58 − 1.05 5.69 10.82 12.10 13.17
28 27 −6.44 −3.66 −1.06 5.81 11.02 12.32 13.41
29 20 −6.61 −3.74 −1.08 5.93 11.22 12.54 13.64
30 35 −6.78 −3.82 −1.09 6.05 11.42 12.76 13.88
31 27 −6.96 −3.90 −1.10 6.16 11.61 12.97 14.11
32 19 −7.14 −3.98 −1.11 6.28 11.81 13.19 14.33
33 25 −7.32 −4.06 −1.13 6.40 12.00 13.40 14.56
34 25 −7.51 −4.14 −1.14 6.51 12.20 13.61 14.79
35 27 −7.70 − 4.22 −1.15 6.63 12.39 13.82 15.01
36 20 −7.89 −4.30 −1.17 6.74 12.58 14.03 15.23
37 20 −8.09 −4.38 −1.18 6.86 12.77 14.23 15.45
38 25 −8.30 −4.46 −1.19 6.97 12.95 14.44 15.67
39 18 −8.51 −4.55 −1.20 7.08 13.14 14.64 15.89
40 2 −8.72 −4.63 −1.22 7.20 13.33 14.84 16.11
Table 7 Percentiles for superior vena cava pulsatility index for
vein (PIV) at 20–40 weeks of gestational age (GA)
Percentile
GA (weeks) n 2.5th 5th 10th 50th 90th 95th 97.5th
20 21 0.93 1.00 1.08 1.49 2.17 2.45 2.74
21 33 0.93 1.00 1.08 1.49 2.17 2.44 2.73
22 30 0.94 1.00 1.09 1.49 2.16 2.44 2.72
23 32 0.94 1.00 1.09 1.49 2.16 2.43 2.72
24 17 0.94 1.01 1.09 1.49 2.16 2.43 2.71
25 30 0.94 1.01 1.09 1.49 2.16 2.43 2.71
26 29 0.95 1.01 1.09 1.49 2.16 2.43 2.70
27 27 0.95 1.01 1.10 1.49 2.16 2.42 2.70
28 26 0.95 1.02 1.10 1.50 2.15 2.42 2.69
29 21 0.95 1.02 1.10 1.50 2.15 2.42 2.69
30 35 0.96 1.02 1.11 1.50 2.15 2.42 2.69
31 27 0.96 1.02 1.11 1.50 2.15 2.42 2.68
32 18 0.96 1.03 1.11 1.51 2.15 2.42 2.68
33 25 0.97 1.03 1.11 1.51 2.16 2.42 2.68
34 25 0.97 1.03 1.12 1.51 2.16 2.41 2.68
35 27 0.97 1.04 1.12 1.51 2.16 2.41 2.68
36 20 0.98 1.04 1.12 1.52 2.16 2.42 2.68
37 20 0.98 1.04 1.13 1.52 2.16 2.42 2.68
38 25 0.98 1.05 1.13 1.52 2.16 2.42 2.68
39 18 0.99 1.05 1.14 1.53 2.16 2.42 2.68
40 2 0.99 1.06 1.14 1.53 2.17 2.42 2.68
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observations. We had an adequate sample size as well as
enough number of observations per gestational week in
the second half of pregnancy (except for the gestational
week 40 and above) to be able to calculate reference per-
centiles with good precision as illustrated in Fig. 2.
The quality of Doppler blood flow veocimetry is oper-
ator dependent, and not reporting intra- and inter-
observer variability could be considered as a limitation
of our study. However, acceptable reproducibility of
SVC velocity measurements has been documented previ-
ously [15]. One may question whether the variation re-
lated to the three experienced operators in our study
reduces the possibility for general use of the references,
and we acknowledge that they may not reflect the mag-
nitude of variation found around the world. On the
other hand, we believe that operators should gain a simi-
lar level of skill to optimize diagnostic performance.
Considering that the pulsatile precordial veins tend to
have a partially blunted rather than a parabolic spatial
blood flow velocity profile [15], our results of SVC
TAMeanV were lower than expected. Compared with
TAMxV, which depends on the maximum velocity tra-
cing at all times during a cardiac cycle, the TAMeanV is
including all pixels recorded and therefore sensitive to
over-representation of low velocities along the zero-line
(e.g. due to clutter and wall movements) that easily
causes underestimation of the pixel intensity-weighted
mean. Our study results therefore support the use of
TAMxV rather than TAMeanV, particularly when calcu-
lating volume blood flow [15, 17].
Our study population was relatively homogenous and
consisted mainly of White European women. As fetal
growth and size vary significantly in different societies
[27] and blood flow is linked to size, we recommend
caution when applying and interpreting the reference
ranges in other populations. Our results underscore this
point showing that SVC Doppler velocities are signifi-
cantly related to fetal head circumference and estimated
fetal weight.
Conclusion
Longitudinal reference intervals of SVC blood flow vel-
ocities and PIV were established for the second half of
pregnancy. The SVC velocities increased with advancing
gestation, while the PIV remained stable from 20 weeks
to term. We believe these measurements have a role in
the fetal assessment as they represent the fetal brain
circulation.
Fig. 2 Longitudinal reference ranges for the fetal superior vena cava (SVC) blood flow velocities and pulsatility index for vein (PIV) based on more
than 500 individual observations (open circles) in 134 pregnancies, presented as mean (red line) with 95% confidence intervals (interrupted red
lines) and 5th and 95th percentiles (interrupted blue lines) with corresponding 95% confidence intervals (interrupted grey lines). Peak systolic (S),
diastolic (D), TAMeanV (time-averaged intensity weighted mean velocity), TAMxV (time-averaged maximum velocity), end-diastolic velocity during
artrial contraction (A-velocity)
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